PIK3CA and melanoma: The fusion of neurotrophic tyrosine kinase type 1 is rare in melanoma but common in other tumors, possibly regulating MAPK/phosphoinositide 3-kinase (PI3K) pathways (48), and its mutation marks Spitz melanoma (49).